newsfilter
← Latest News
Business Wire·

Alpine Immune Sciences to Participate in the SVB Securities Global Biopharma Conference

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the Company will present a